This inventor holds 5 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 3 EPO patents. Top assignee: Technion Research & Development Foundation Ltd. Active years: 2014-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Kiryat-Haim, IL (2014 - 2015)
- Kiryat-Yam, IL (2017 - 2018)
Company Filing History:
Years Active: 2014-2018
Title: Innovations of Mariana Hainrichson
Introduction
Mariana Hainrichson is a notable inventor based in Kiryat-Haim, Israel. She has made significant contributions to the field of genetic disorders through her innovative research and development. With a total of 5 patents, her work focuses on aminoglycosides and their applications in treating genetic conditions.
Latest Patents
Hainrichson's latest patents include a new class of paromomycin-derived aminoglycosides. These compounds exhibit efficient stop-codon mutation suppression activity, low toxicity, and high selectivity towards eukaryotic cells. The patents also detail chemical and chemo-enzymatic processes for preparing these aminoglycosides and their intermediates. Additionally, pharmaceutical compositions containing these compounds are described, along with their uses in the treatment of genetic disorders.
Career Highlights
Mariana Hainrichson is affiliated with the Technion Research & Development Foundation Limited, where she continues to advance her research. Her work has garnered attention for its potential impact on the treatment of genetic disorders, showcasing her dedication to innovation in the field.
Collaborations
Hainrichson collaborates with esteemed colleagues, including Timor Baasov and Tamar Ben-Yosef. These partnerships enhance her research efforts and contribute to the development of groundbreaking solutions in genetic medicine.
Conclusion
Mariana Hainrichson's contributions to the field of genetic disorders through her innovative patents highlight her role as a leading inventor. Her work not only advances scientific knowledge but also holds promise for improving patient outcomes in the treatment of genetic conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile